| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies, Inc. | Director | Stock Option (Right to Buy) | 10.5K | Jun 17, 2025 | Direct | ||
| Actinium Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 0 | Mar 31, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ADVM | Adverum Biotechnologies, Inc. | Jun 17, 2025 | 1 | $0 | 4 | Jun 20, 2025 | Director |
| ATNM | Actinium Pharmaceuticals, Inc. | Mar 31, 2025 | 8 | $0 | 4 | Apr 2, 2025 | Director |
| ADVM | Adverum Biotechnologies, Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
| ATNM | Actinium Pharmaceuticals, Inc. | Dec 28, 2023 | 1 | $0 | 4 | Dec 29, 2023 | Director |
| ADVM | Adverum Biotechnologies, Inc. | Nov 3, 2023 | 1 | $0 | 4 | Nov 6, 2023 | Director |
| ADVM | Adverum Biotechnologies, Inc. | Nov 3, 2023 | 0 | $0 | 3 | Nov 6, 2023 | Director |
| ATNM | Actinium Pharmaceuticals, Inc. | Jul 1, 2022 | 1 | $0 | 4 | Jul 1, 2022 | Director |
| ATNM | Actinium Pharmaceuticals, Inc. | Sep 1, 2021 | 1 | $0 | 4 | Sep 3, 2021 | Director |